Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation

Area of Science:

• Cardiovascular Biology
• Cell Cycle Regulation
• Lipid Metabolism

Background:

• High-density lipoprotein (HDL) and its associated apolipoprotein E (APOE) are known to influence vascular smooth muscle cell (VSMC) function.
• The precise molecular mechanisms by which APOE and HDL exert their effects on cell cycle progression remain incompletely understood.

Purpose of the Study:

• To elucidate the role of APOE and HDL in regulating VSMC S-phase entry.
• To identify the specific domains and signaling pathways involved in the antimitogenic effects of APOE.
• To investigate the link between APOE/HDL signaling and the prostacyclin pathway.

Main Methods:

• Investigated the antimitogenic effects of APOE and its N-terminal domain on murine aortic smooth muscle cells.
• Analyzed the impact on cyclin A promoter activation using pocket protein-dependent and independent pathways.
• Assessed the role of cyclooxygenase-2 (Cox-2) expression and prostacyclin synthesis.
• Utilized human aortic smooth muscle cells and APOE-overexpressing mice for in vivo validation.

Main Results:

• The antimitogenic effect of APOE was localized to its N-terminal receptor-binding domain.
• APOE and its N-terminal domain inhibited cyclin A promoter activation.
• HDL and APOE suppressed VSMC cell cycle progression by stimulating Cox-2 expression, leading to prostacyclin synthesis.
• This process involved prostacyclin receptor IP-dependent inhibition of the cyclin A gene.

Conclusions:

• APOE signaling targets the Cox-2 gene, linking HDL and APOE to prostacyclin receptor IP action.
• HDL and APOE suppress VSMC proliferation through a Cox-2/prostacyclin-dependent pathway.
• This mechanism provides a potential new basis for the cardioprotective effects of HDL and APOE in cardiovascular disease.